{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000922","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.468543+00:00","generated_at":"2026-05-24T03:57:28.316716+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Co-Diagnostics FY2024 revenue $3.9M, net loss $37.6M; withdraws 510(k) for platform","bullets":["Revenue $3.9M vs $6.8M in 2023; product revenue $0.8M, grant revenue $3.1M.","Net loss $37.6M ($1.24/diluted share) vs $35.3M ($1.20) prior year.","Adjusted EBITDA loss of $33.5M; operating expenses $43.0M decreased 5.2% YoY.","Cash and marketable securities $29.7M as of Dec 31, 2024.","Withdrew initial 510(k) for Co-Dx PCR Pro; plans to resubmit enhanced version."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000922","json":"https://secwatch.observer/filing/0001641172-25-000922.json","markdown":"https://secwatch.observer/filing/0001641172-25-000922.md","text":"https://secwatch.observer/filing/0001641172-25-000922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000164117225000922/0001641172-25-000922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000164117225000922/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:57:28.316716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}